Financial Services
Advisory
China, United States
M&A Advisory
M&A Advisory Firm
Industry:
Financial Services
Location:
China, United States
Year:
2017
Full Credential Description
SciClone Pharmaceuticals, Inc.. China, United States. Announced Date 08/06/2017. Closed Date 13/10/2017. Deal value: $605m. SciClone to be acquired by consortium led by GL Capital. Industry: SciClone Pharmaceuticals, Inc. operates in the pharmaceutical industry, focusing on the development and commercialization of therapies for oncology, infectious diseases, and cardiovascular disorders.
Measurable Results
$605.0M